Cargando…

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study

Advanced glycation end‐products (AGEs), which bind to type 1 collagen in bone and skin, have been implicated in reduced bone quality. The AGE reader™ measures skin autofluorescence (SAF), which might be regarded as a marker of long‐term accumulation of AGEs in tissues. We investigated the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Waqas, Komal, Chen, Jinluan, Koromani, Fjorda, Trajanoska, Katerina, van der Eerden, Bram CJ, Uitterlinden, André G, Rivadeneira, Fernando, Zillikens, M Carola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687120/
https://www.ncbi.nlm.nih.gov/pubmed/32463533
http://dx.doi.org/10.1002/jbmr.4096
_version_ 1783613461152923648
author Waqas, Komal
Chen, Jinluan
Koromani, Fjorda
Trajanoska, Katerina
van der Eerden, Bram CJ
Uitterlinden, André G
Rivadeneira, Fernando
Zillikens, M Carola
author_facet Waqas, Komal
Chen, Jinluan
Koromani, Fjorda
Trajanoska, Katerina
van der Eerden, Bram CJ
Uitterlinden, André G
Rivadeneira, Fernando
Zillikens, M Carola
author_sort Waqas, Komal
collection PubMed
description Advanced glycation end‐products (AGEs), which bind to type 1 collagen in bone and skin, have been implicated in reduced bone quality. The AGE reader™ measures skin autofluorescence (SAF), which might be regarded as a marker of long‐term accumulation of AGEs in tissues. We investigated the association of SAF with bone mineral density (BMD) and fractures in the general population. We studied 2853 individuals from the Rotterdam Study with available SAF measurements (median age, 74.1 years) and with data on prevalent major osteoporotic (MOFs: hip, humerus, wrist, clinical vertebral) and vertebral fractures (VFs: clinical + radiographic Genant’s grade 2 and 3). Radiographs were assessed 4 to 5 years before SAF. Multivariate regression models were performed adjusted for age, sex, BMI, creatinine, smoking status, and presence of diabetes and additionally for BMD with interaction terms to test for effect modification. Prevalence of MOFs was 8.5% and of VFs 7%. SAF had a curvilinear association with prevalent MOFs and VFs and therefore, age‐adjusted, sex stratified SAF quartiles were used. The odds ratio (OR) (95% confidence interval [CI]) of the second, third and fourth quartiles of SAF for MOFs were as follows: OR 1.60 (95% CI, 1.08–2.35; p = .02); OR 1.30 (95% CI, 0.89–1.97; p = .20), and OR 1.40 (95% CI, 0.95–2.10; p = .09), respectively, with first (lowest) quartile as reference. For VFs the ORs were as follows: OR 1.69 (95% CI, 1.08–2.64; p = .02), OR 1.74(95% CI, 1.11–2.71; p = .01), and OR 1.73 (95% CI, 1.12–2.73; p = .02) for second, third, and fourth quartiles, respectively. When comparing the top three quartiles combined with the first quartile, the OR (95% CI) for MOFs was 1.43 (95% CI, 1.04–2.00; p = .03) and for VFs was 1.72 (95% CI, 1.18–2.53; p = .005). Additional adjustment for BMD did not change the associations. In conclusion, there is evidence of presence of a threshold of skin AGEs below which there is distinctly lower prevalence of fractures. Longitudinal analyses are needed to confirm our cross‐sectional findings. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-7687120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-76871202020-12-03 Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study Waqas, Komal Chen, Jinluan Koromani, Fjorda Trajanoska, Katerina van der Eerden, Bram CJ Uitterlinden, André G Rivadeneira, Fernando Zillikens, M Carola J Bone Miner Res Original Articles Advanced glycation end‐products (AGEs), which bind to type 1 collagen in bone and skin, have been implicated in reduced bone quality. The AGE reader™ measures skin autofluorescence (SAF), which might be regarded as a marker of long‐term accumulation of AGEs in tissues. We investigated the association of SAF with bone mineral density (BMD) and fractures in the general population. We studied 2853 individuals from the Rotterdam Study with available SAF measurements (median age, 74.1 years) and with data on prevalent major osteoporotic (MOFs: hip, humerus, wrist, clinical vertebral) and vertebral fractures (VFs: clinical + radiographic Genant’s grade 2 and 3). Radiographs were assessed 4 to 5 years before SAF. Multivariate regression models were performed adjusted for age, sex, BMI, creatinine, smoking status, and presence of diabetes and additionally for BMD with interaction terms to test for effect modification. Prevalence of MOFs was 8.5% and of VFs 7%. SAF had a curvilinear association with prevalent MOFs and VFs and therefore, age‐adjusted, sex stratified SAF quartiles were used. The odds ratio (OR) (95% confidence interval [CI]) of the second, third and fourth quartiles of SAF for MOFs were as follows: OR 1.60 (95% CI, 1.08–2.35; p = .02); OR 1.30 (95% CI, 0.89–1.97; p = .20), and OR 1.40 (95% CI, 0.95–2.10; p = .09), respectively, with first (lowest) quartile as reference. For VFs the ORs were as follows: OR 1.69 (95% CI, 1.08–2.64; p = .02), OR 1.74(95% CI, 1.11–2.71; p = .01), and OR 1.73 (95% CI, 1.12–2.73; p = .02) for second, third, and fourth quartiles, respectively. When comparing the top three quartiles combined with the first quartile, the OR (95% CI) for MOFs was 1.43 (95% CI, 1.04–2.00; p = .03) and for VFs was 1.72 (95% CI, 1.18–2.53; p = .005). Additional adjustment for BMD did not change the associations. In conclusion, there is evidence of presence of a threshold of skin AGEs below which there is distinctly lower prevalence of fractures. Longitudinal analyses are needed to confirm our cross‐sectional findings. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2020-06-22 2020-10 /pmc/articles/PMC7687120/ /pubmed/32463533 http://dx.doi.org/10.1002/jbmr.4096 Text en © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Waqas, Komal
Chen, Jinluan
Koromani, Fjorda
Trajanoska, Katerina
van der Eerden, Bram CJ
Uitterlinden, André G
Rivadeneira, Fernando
Zillikens, M Carola
Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title_full Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title_fullStr Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title_full_unstemmed Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title_short Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
title_sort skin autofluorescence, a noninvasive biomarker for advanced glycation end‐products, is associated with prevalent vertebral and major osteoporotic fractures: the rotterdam study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687120/
https://www.ncbi.nlm.nih.gov/pubmed/32463533
http://dx.doi.org/10.1002/jbmr.4096
work_keys_str_mv AT waqaskomal skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT chenjinluan skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT koromanifjorda skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT trajanoskakaterina skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT vandereerdenbramcj skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT uitterlindenandreg skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT rivadeneirafernando skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy
AT zillikensmcarola skinautofluorescenceanoninvasivebiomarkerforadvancedglycationendproductsisassociatedwithprevalentvertebralandmajorosteoporoticfracturestherotterdamstudy